Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2025-12-25 @ 9:34 PM
Study NCT ID:
NCT01455051
Status:
COMPLETED
Last Update Posted:
2022-05-06
First Post:
2011-10-17
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Ofatumumab as Part of Reduced Intensity Conditioning (RIC) Regimen for Patients With High Risk Chronic Lymphocytic Leukemia (CLL) Undergoing Allogeneic Hematopoietic Cell Transplantation
Sponsor:
Grupo Espanol de trasplantes hematopoyeticos y terapia celular
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-10
Start Date Type:
None
Primary Completion Date:
2014-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-10
Completion Date Type:
ACTUAL
First Submit Date:
2011-10-17
First Submit QC Date:
None
Study First Post Date:
2011-10-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-02
Last Update Post Date:
2022-05-06
Last Update Post Date Type:
ACTUAL